Skip to main content
Log in

Synthesis, Antiinflammatory, and Cytotoxic Activities of 2-Alkyl and 2-Benzyl-2-Dimethylaminomethyl-5-(E)-Arylidene Cyclopentanone Hydrochlorides

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. A series of 2-substituted-2-dimethylaminomethyl-5-(E)-arylidene cyclopentanones, 4 were synthesized. The main objective of this investigation was to explore the structural parameters necessary for antiinflammatory activity in this series of compounds, while keeping cytotoxic action to a minimum.

Methods. The target compounds were synthesized in two steps commencing with 2-alkyl-cyclopentanones. Antiinflammatory, analgesic and cytotoxic activities were determined in rats. Cytotoxic results were examined in human cell lines.

Results. Eight of the eighteen synthetic substances possessed significant antiinflammatory activity and twelve showed appreciable analgesic action. Cytotoxicity was minimal or non-existent for most of the compounds. The stability of one of the compounds, 4b in both aqueous and non-aqueous media, and an amine exchange reaction with aniline were used to explain the observed antiinflammatory and cytotoxic activities.

Conclusions. Unlike monosubstituted aminomethyl groups (Mannich bases) at the 2-position of 5-arylidene-2-cyclopentanones, a second substituent at the 2-position increases stability of the Mannich base and significantly decreases cytotoxic activity. Antiinflammatory and analgesic action is retained in many of the compounds, thus strongly indicating that these desired pharmacological results can be obtained without untoward damage to cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. H. Chen, Y. Jing, Z. Ji, and B. Zhang. Acta Pharmaceutica Sinica. 26:183–192 (1991).

    Google Scholar 

  2. H. Chen, Z. Ji, L. Wong, J. F. Siuda, and V. L. Narayanan. Bioorgan. & Med. Chem. 2:1091–1097 (1994).

    Google Scholar 

  3. H. Wu, M. Ge, C. Yu, S. Li, and Y. Cheng. J. Bengbu Medical College. 16:234–237 (1991).

    Google Scholar 

  4. G. Elias, and M. N. A. Bao. Eur. J. Med. Chem. 23:379–380 (1988).

    Google Scholar 

  5. G. B. Singh, G. D. Leach and C. K. Atal. Arzneim-Forsch. 37:708–712 (1987).

    Google Scholar 

  6. G. B. Singh, G. D. Leach and C. K. Atal. Arznein-Forsch. 37:435–440 (1987).

    Google Scholar 

  7. E. E. Galantay. U.S. Patent. 4,273,787.

  8. I. Katsumi, H. Kondo, K. Yamashita, K. Hosoe, T. Yamashita and K. Watanabe. Chem. Pharm. Bull. 34:121–124 (1986).

    Google Scholar 

  9. H. Shirota, K. Chiba, H. Ono, H. Yamamoto, S. Kobayashi, K. Terato, H. Ikuta, I. Yamatsu and K. Katayama. Arzneim-Forsch. 37:930–936 (1987).

    Google Scholar 

  10. Y. C. Martin. Quantitative Drug Design. Grunewald, G. L. ed. Marcel Dekker, Inc. New York, 1978, pp. 378–393.

    Google Scholar 

  11. A. Verloop, W. Hoogenstraaten and J. Tipker. Drug Design, Vol II., E. J. Ariens ed.; Academic Press, New York, 1976.

    Google Scholar 

  12. R. Mayer. Chem. Ber. 88:1853–1858 (1955).

    Google Scholar 

  13. A. Hassner and T. C. Mead. Tetrahedron Letters. 1223–1224 (1962).

  14. C. A. Winter, E. A. Risley and G. A. Nuss. J. Pharmacology & Experimental Therapeutics 141:369–376 (1963).

    Google Scholar 

  15. E. Siegmund, R. Cadmus and G. Lu. Pro. Soc. Exp. Biol. Med. 95:729–731 (1959).

    Google Scholar 

  16. H. Chen, Z. Ji, L. Wong, J. F. Siuda and V. L. Narayanan. Drug Design and Discovery, in press.

  17. M. R. Boyd. In Cancer: Principles and Practice of Oncology Update; Devita, V. T., Jr., Ed.; J. B. Lippincott: Philadelphia, 1989; 3(10), pp 1–12.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, H., Ji, Z., Wong, L.K. et al. Synthesis, Antiinflammatory, and Cytotoxic Activities of 2-Alkyl and 2-Benzyl-2-Dimethylaminomethyl-5-(E)-Arylidene Cyclopentanone Hydrochlorides. Pharm Res 13, 1482–1487 (1996). https://doi.org/10.1023/A:1016067210281

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016067210281

Navigation